Reduced Intensity Conditioning Ric | List of Frontiers open access articles

Review

Published on 15 Apr 2021

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia

in Hematologic Malignancies

Justin Loke
Hrushikesh Vyas
Charles Craddock

Frontiers in Oncology

doi 10.3389/fonc.2021.666091

6,865 views
18 citations

Review

Published on 02 May 2012

The use of donor-derived veto cells in hematopoietic stem cell transplantation

in Alloimmunity and Transplantation

Eran Ophir
Yair Reisner

Frontiers in Immunology

doi 10.3389/fimmu.2012.00093

7,645 views
10 citations

Brief Research Report

Published on 12 Jun 2023

Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon

in Cell and Stem Cell Transplantation

Jean El Cheikh
Ghassan Bidaoui
Layal Sharrouf
Ammar Zahreddine
Radwan Massoud
Rita Nehme
Nabila Kreidieh
Nour Moukalled
Iman Abou Dalle
Rami Mahfouz

Frontiers in Transplantation

doi 10.3389/frtra.2023.1149393

2,275 views
1 citation

Original Research

Published on 24 Sep 2021

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients

in Alloimmunity and Transplantation

Joanne E. Davis
Kelei Du
Mandy J. Ludford-Menting
Ashvind Prabahran
Eric Wong
Nicholas D. Huntington
Rachel M. Koldej
David S. Ritchie

Frontiers in Immunology

doi 10.3389/fimmu.2021.749094

6,721 views
12 citations

Review

Published on 03 May 2021

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?

in Alloimmunity and Transplantation

Justin Loke
Richard Buka
Charles Craddock

Frontiers in Immunology

doi 10.3389/fimmu.2021.659595

41,466 views
92 citations

Original Research

Published on 02 Feb 2021

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

in Alloimmunity and Transplantation

Agnieszka Tomaszewska
Madan Jagasia
Eric Beohou
Steffie van der Werf
Didier Blaise
Edward Kanfer
Noel Milpied
Péter Reményi
Fabio Ciceri
Jean H. Bourhis

Frontiers in Immunology

doi 10.3389/fimmu.2020.613954

4,040 views
5 citations

Original Research

Published on 29 Jul 2020

Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan

in Primary Immunodeficiencies

Masakatsu Yanagimachi
Koji Kato
Akihiro Iguchi
Koji Sasaki
Chikako Kiyotani
Katsuyoshi Koh
Takashi Koike
Hideki Sano
Tomonari Shigemura
Hideki Muramatsu

Frontiers in Immunology

doi 10.3389/fimmu.2020.01617

6,995 views
18 citations

Articles

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia

The use of donor-derived veto cells in hematopoietic stem cell transplantation

Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan